Nu Skin Enterprises Inc. (NYSE:NUS) rose 5.2% on Monday . The company traded as high as $60.48 and last traded at $60.48, with a volume of 356,022 shares changing hands. The stock had previously closed at $57.51.

NUS has been the subject of a number of recent research reports. Jefferies Group initiated coverage on shares of Nu Skin Enterprises in a research report on Friday, June 3rd. They set a “hold” rating and a $41.00 price objective for the company. Pivotal Research boosted their price objective on shares of Nu Skin Enterprises from $55.00 to $60.00 and gave the company a “buy” rating in a research report on Thursday, June 16th. Zacks Investment Research raised shares of Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $52.00 price objective for the company in a research report on Tuesday, June 21st. Citigroup Inc. boosted their target price on shares of Nu Skin Enterprises from $45.00 to $52.00 and gave the company a “buy” rating in a research note on Friday, July 1st. Finally, Deutsche Bank AG reissued a “hold” rating and set a $55.00 target price (up from $45.00) on shares of Nu Skin Enterprises in a research note on Sunday, July 24th. Two research analysts have rated the stock with a sell rating, four have issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. Nu Skin Enterprises has a consensus rating of “Hold” and a consensus target price of $48.92.

The company’s 50 day moving average is $57.37 and its 200-day moving average is $44.86. The firm has a market capitalization of $3.34 billion, a price-to-earnings ratio of 34.23 and a beta of 1.75.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Thursday, August 4th. The company reported $0.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.78 by $0.01. Nu Skin Enterprises had a net margin of 4.52% and a return on equity of 18.46%. The company earned $600.05 million during the quarter, compared to analysts’ expectations of $578.87 million. During the same quarter in the prior year, the company posted $0.75 EPS. The business’s revenue was up 7.2% on a year-over-year basis. On average, equities research analysts predict that Nu Skin Enterprises Inc. will post $2.88 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 14th. Stockholders of record on Friday, August 26th were paid a $0.355 dividend. This represents a $1.42 dividend on an annualized basis and a dividend yield of 2.38%. The ex-dividend date was Wednesday, August 24th. Nu Skin Enterprises’s dividend payout ratio is 81.14%.

Several institutional investors have recently made changes to their positions in the stock. Metropolitan Life Insurance Co. NY boosted its position in shares of Nu Skin Enterprises by 3.4% in the second quarter. Metropolitan Life Insurance Co. NY now owns 2,349 shares of the company’s stock worth $109,000 after buying an additional 77 shares in the last quarter. Parametrica Management Ltd purchased a new stake in shares of Nu Skin Enterprises during the second quarter worth about $207,000. M&T Bank Corp purchased a new stake in shares of Nu Skin Enterprises during the second quarter worth about $209,000. CIBC World Markets Inc. purchased a new stake in shares of Nu Skin Enterprises during the second quarter worth about $211,000. Finally, Hsbc Holdings PLC purchased a new stake in shares of Nu Skin Enterprises during the second quarter worth about $214,000. Institutional investors own 77.08% of the company’s stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum.

5 Day Chart for NYSE:NUS

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.